Sold and Supplied by Healthylife Pharmacy

Arimidex Anastrozole (1mg) 30 Tablets

This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.

Medicare CardNo MedicareConcession

$15.95

Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.

DescriptionWhat is Arimidex Anastrozole (1mg)?

• Anastrozole (Anastro-y) is primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
• Healthylife offers several different formulations of anastrozole, including brand name Arimidex, generic Anastrozole and the brand name Arimidex DS. In addition to brand name Anastrozole, Healthylife contains a blend of purity and performanceELLY! Arimidex is a medication specifically designed to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing the effects of estrogen in the body, which can aid in the treatment of hormone receptor-positive breast cancer by reducing the growth of hormone receptor-positive breast cancer cells.
• Healthylife offers several formulations of Arimidex, including anastrozole, anastrozole DS, anastrozole and Arimidex. In Arimidex, Arimidex is a medication specifically designed to treat breast cancer in postmenopausal women. Arimidex is a hormonal treatment that has been proven to be effective in reducing the risk of recurrence and death in postmenopausal women, particularly those who have gone on to develop breast cancer. Arimidex is indicated for the adjunctive treatment of breast cancer in postmenopausal women with hormone receptor-positive disease.

This information is intended as a guide only, but healthylife.com.au provides the comparison between NHS and other P& G medications onb21pharmacy.com.au. TheMedicaid.com.au editorial team balanced information on various products, including our Medical and Healthcare products Council (MHC) ratings, which are the standards and evaluations provided by a medical professional. If you have any questions about the information above, please speak to the manufacturer.

In conclusionWhat is Anastrozole (Anastro-y)?Injection

General Product Information

• Healthylife offers several different formulations of anastrozole, including brand name Anastrozole, generic Anastro-y, and the brand name Anastro-y DS. In addition to brand name Anastro-y, Healthylife contains a blend of purity and performanceELLY! Anastrozole is a medication specifically designed to treat breast cancer in postmenopausal women.
• Healthylife offers several formulations of Anastrozole, including brand name Anastro-y, generic Anastro-y and the brand name Anastro-y DS.

Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.

The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.

If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.

How common is Arimidex 1mg?

Note:The safety studies of Arimidex 1mg have not been performed in the Australian market. To ensure the data are fact, we conducted a retrospective analysis of all patients taking Arimidex 1mg from 2018 to 2031. In this analysis, we evaluated the safety of Arimidex 1mg for the treatment of hormone-dependent breast cancer in postmenopausal women.

Safety of Arimidex 1mg in women

Key takeaway: Arimidex 1mg is an aromatase inhibitor. It reduces estrogen levels by preventing enzyme in adipose tissue from converting other hormones into estrogen.

Effects of Arimidex 1mg on body weight

Side effects: Nausea, vomiting, headache, breast pain, bone pain, decreased appetite, diarrhea, flatulence, constipation, dizziness, dry mouth, drowsiness, drowsiness, weight gain, and weakness.

Effects of Arimidex 1mg on metabolic profile in patients

Interactions: Medicines that may interact with Arimidex 1mg include certain anti-diabetic medicines, blood pressure medicines, cholesterol medicines, antibiotics, and anti-inflammatory medicines.

Effects of Arimidex 1mg on men

Product details:

Arimidex 1mg tablet is a prescription medicine used to treat hormone-dependent breast cancer in postmenopausal women. Arimidex 1mg tablets are also used to treat advanced breast cancer in postmenopausal women with hormone receptor-positive early breast cancer.

To treat hormone-dependent breast cancer in postmenopausal women with advanced breast cancer, the adjuvant therapy can be used after the surgery.

Contraindications of Arimidex 1mg

Note

1. Have or have had an ovarian tumor, any kind of cancer, or any kind of tumour.
2. Have a history of blood clots.
3. Have breast cancer.
4. Have a family history of liver disease.
5. Have a family history of kidney disease.
6. Have liver disease.
7. Have adrenal insufficiency.
8. Have severe liver disease.
9. Have severe kidney disease.
10. Have severe blood clots.

“There’s been a lot of talk about whether this drug could be effective at helping women to gain their sex lives,” said Dr. Shukla Sharma, a fertility expert at the University of Washington in Seattle. “This is not the case.”

The study, published in the International Journal of Sex Research, is part of a larger effort to explore the possible impact of Arimidex (anastrozole) on the hypothalamic-pituitary-gonadal (HPG) axis in premenopausal women. Arimidex, or anastrozole, is a drug that blocks estrogen in the body. In a study of 11,639 women over age 50, Arimidex was more effective at improving the HPG axis than tamoxifen, or tamoxifen plus a placebo. The effects of Arimidex were similar in women who received the drug, and those who received tamoxifen, were similar in those who received the drug. The results suggest that Arimidex may have some benefit, but not all, in treating women with early-stage hormone receptor positive (ER+NHR+) premenopausal women with endometriosis or hormone receptor negative (HR+NHR-) women with endometriosis. The study does not directly examine the effect of Arimidex on the HPG axis.

Researchers from the University of Washington, Seattle, recruited 10,639 women and randomized them to receive either Arimidex (anastrozole) or tamoxifen, or placebo plus anastrozole. The women were followed for at least one year to determine whether they experienced improved quality of life and were then evaluated in terms of their desire to have sex. For each of the 10,639 women, Arimidex was assessed in terms of sexual desire, arousal, and duration of intercourse. Women who took the drugs had significantly better outcomes when compared with those who took tamoxifen alone, but did not have any difference in terms of time to ovulation and time to ovulation.

“This is one of the few studies that has been done to evaluate the impact of Arimidex on the HPG axis in premenopausal women,” said Dr. Sharma. “This study has the potential to lead to a better understanding of the relationship between estrogen use and the HPG axis, but it is not the first time we’ve looked at the impact of Arimidex on the HPG axis.”

While Arimidex is used to treat hormone receptor positive (HR+NHR+) postmenopausal women, the drug is not approved for use in women who have endometriosis, endometrial hyperplasia, or other cancers.

Aromatase inhibitors, such as tamoxifen and Arimidex, are commonly prescribed for women with endometriosis. Arimidex is also used to treat advanced endometriosis in advanced stage IV endometrial hyperplasia.

Arimidex is a selective estrogen receptor modulator (SERM) that was approved by the FDA in 1999 for the treatment of hormone receptor positive (HR+) endometrial hyperplasia. However, Arimidex is not approved for use in postmenopausal women with endometriosis, HR+NHR+, or other cancers, and has not been studied for women who have or have had endometriosis. This means that the drug may not be effective in women with endometriosis who do not have a hormone receptor positive disease.

Arimidex has been used to treat estrogen-dependent breast cancer in postmenopausal women since 2005, and has been shown to reduce the risk of endometrial hyperplasia and cancer.

In the study, women who took the drug had significantly better outcomes than women who took tamoxifen alone. The researchers compared Arimidex and tamoxifen with anastrozole, and found that both drugs were superior to tamoxifen in terms of treating hormone receptor positive (HR+) endometrial hyperplasia and cancer.

Arimidex was also superior to tamoxifen in treating the HPG axis in women with HR+NHR+ or HR+NHR+ HR+ or HR+NHR- breast cancer, and had no impact on the overall endometrial health of the women. These results are the first to show that Arimidex is more effective than tamoxifen in the treatment of hormone receptor positive premenopausal women with endometriosis, HR+NHR+, or HR+NHR+ HR+ breast cancer.

The Arimidex 1mg Tablet 14s is a vital pharmaceutical product utilized foraddressing particular forms of breast cancer.The tablet comprisesAnastrozole, an active agent that is part of thearomatase inhibitorsdrug category.

The operational mechanism of this medicine involvessuppressing an enzyme referred to as aromatase,that is involved inestrogen synthesis.By obstructingaromatase,a decline in estrogen levels occurs, which is successful indecelerating or haltingthe progression ofestrogen-receptivebreast cancers. In less complex language,is utilized tooffset the impactsof estrogen, significantlyaiding the treatmentplan for specific breast cancers.

Obstructing the function of thearomatase enzymethroughleads to a consequentialreduction in estrogenlevels. Since certainbreast cancersare dependent on estrogen for their development, this decline in estrogen helps tocurtail the advancement of the cancer.

It's vital tocomply with your doctor's guidelineswhen taking this medication. The pill can be ingestedwith or without nourishment, but sticking to a consistent daily routine is advised for best outcomes.

Using this medication may cause a decline in bone mineral density, increasing the vulnerability to fractures.It is crucial tomonitor bone health regularly,especiallyfor postmenopausal women.Proper consumptionof calcium and vitamin D, combined with weight-bearing physical activities, could be suggested.Postmenopausal femalesusingmight experience a higher probability of developingosteoporosis,whichmandates bone density testsand appropriatepreventative actions.

Side effectslinked with its intake might encompass diarrhea, nausea, osteoporosis, headaches, vaginal bleeding or dryness, sensory disturbances, hot flushes, alopecia, bone soreness, andhypercholesterolemia.

If you forget to take a dose, it should be taken as soon as remembered. If the next dose is due soon, ignore the missed one and maintain the regular schedule.Do not take extra doses to compensate.Consult your healthcare professional for strategies to manage forgotten doses efficiently.Finishingthe prescribed course of the medication is vital forachieving the maximum treatment outcomes.

View SourceViewazaroo

The active agentinthis medicine aid inaddressing a broad range of specific types of breast cancer.

The case studies affirm the efficacyof Anastrozolein the treatment of female infertility. These examples highlight thepotential risks and benefits of combining this medication with female fertility treatments.

Aromatase Inhibitors

The operational mechanism involvessterile aromatase,which is involved inestrogen synthesisand prevents further decline in estrogen levels. Bysuppressing an enzyme calledAromthat is referred to asArimidex, also referred to as anastrozole, obstructs estrogen’s function.

A decline in estrogen levels occurs, which is successful inrescribing orribing strategicameful>(oral) use for specific breast cancers.Arimidexoffset the effectsmandates acomparison ofwith estrogens-containing medications like Irbesartan and Eplerenone, which are commonly used to counteract the effects of estrogen.